Skip to main content
. 2019 Oct 25;105(3):e70–e84. doi: 10.1210/clinem/dgz093

Table 1.

Indices of GH Action in Targeted Cohort of IGSF1-Deficient Male Patients

Patients Reference Data Source and Range P Value
n 21
Age (y) 55.1 (21.8–85.2)
BMI (kg/m2) 27.4 (24.4–34.6)
Classified as acromegalic (%)a 52.4 19.1b 0.024
Finger soft-tissue thickness (SDS)c 1.1 (-0.3 to 2.3) (9) 0.001
Adult height SDS -0.4 (-1.7 to 1.0) (10, 11) 0.138
Head circumference (SDS) 1.3 (0.1–2.4) (12) <0.001
Fat mass index (SDS)d -0.08 (-0.94 to 4.95) (13) 0.175
Fat free mass index (SDS)d 0.40 (-2.42 to 1.92) (13) 0.793
IGF-1 (SDS) 1.0 (-0.1 to 2.9) In-house (age-dependent) 0.001
Free T4 (pmol/L) 14.3 (8.9–21.9) 12.0–22.0 pmol/L
Prolactin (µg/L) 4.3 (1.4–15.4) 4.0–15.0 µg/L
Testosterone (nmol/L) 14.3 (7.9–22.1) 8.0–31.0 nmol/L
Cortisol (µmol/L) 0.355 (0.196–0.533) 0.100–0.600 µmol/L
Testicular volume (SDS)e 2.9 (1.2–5.8) (14) <0.001

Data presented as number or median (P10-P90).

Abbreviations: BMI, body mass index; SDS, standard deviation score.

aBased on software analysis of facial photographs.

bBased on 18 in-house age- and BMI-matched controls.

cN = 20.

dCorrected for BMI and height, available n = 19 for fat mass index and n = 16 for fat-free mass index.

eUltrasonographic volume of largest testis, n = 16.